first in class - Robuta Search

https://www.naval-technology.com/news/indian-navy-to-commission-first-in-class-survey-ship-sandhayak/ Indian Navy to commission first in class survey ship, Sandhayak - Naval Technology Feb 1, 2024 - India's Navy will commission its latest survey ship, the first in class Sandhayak, on 3 February, adding to its deep-sea survey capacity. first in class indian navy https://www.painreliefwa.org/2025/02/04/fda-approves-journavx-first-in-class-non-opioid-pain-medication-for-acute-pain/ FDA Approves Journavx, First-in-Class Non-Opioid Pain Medication for Acute Pain - Pain Relief... Feb 4, 2025 - The FDA has approved Journavx (suzetrigine), a first-in-class non-opioid pain medication for adults experiencing moderate to severe acute pain. Developed by... first in class https://cordis.europa.eu/project/id/101067731 First-in-class beta-catenin inhibitor as treatment for colorectal cancer | proCOLON | Project |... With more than 1.9 million new cases and 935,000 related deaths in 2020, colorectal cancer (CRC) is the third most common cancer in men and the second in... first in class https://www.oxfordbiotherapeutics.com/ Developing First-in-Class Cancer Therapies | Oxford BioTherapeutics At Oxford BioTherapeutics, we are dedicated to pioneering the next generation of oncology treatments through targeted therapies, including Antibody-Drug... first in class cancer therapies developing oxford biotherapeutics https://www.painreliefwa.org/2025/02/04/fda-approves-journavx-first-in-class-non-opioid-pain-medication-for-acute-pain-2/ FDA Approves Journavx, First-in-Class Non-Opioid Pain Medication for Acute Pain - Pain Relief... Feb 4, 2025 - The FDA has approved Journavx (suzetrigine), a first-in-class non-opioid pain medication for adults experiencing moderate to severe acute pain. Developed by... first in class https://www.novochizol.ch/ Novochizol | First-in-class polysaccharide nanospheres. Aug 3, 2025 - Novochizol SA is a Swiss biotech company with a unique chitosan-based drug formulation, first-in-class polysaccharide nanospheres. first in class polysaccharide https://lipum.se/ Lipum - We develop an anti-inflammatory drug with first-in-class potential Mar 24, 2026 - Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases. first in class we develop anti inflammatory https://www.bergenbio.com/ BerGenBio - Developing first-in-class AXL inhibitors for aggressive disease BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers first in class developing axl inhibitors aggressive https://www.creativebio.tech/ CBT | First in Class Biotech Creative BioTherapeutics is an emerging Biotech that focuses on the root cause of drug resistance and immune evasion for cancer, viruses and other illnesses.... first in class cbt biotech https://pmc.ncbi.nlm.nih.gov/articles/PMC7839263/ Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension:... An unfortunate subset of hypertensive patients develops resistant hypertension in which optimal doses of three or more first-line antihypertensive drugs fail... first in class https://www.imtm.cz/publication/impact-factor-journals/baxdrostat-first-class-aldosterone-synthase-inhibitor-resistant?language=cs Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension | Institute... first in class https://zedira.com/News/Zedira-publication-Features-of-ZED1227-The-First-In-Class-Tissue-Transglutaminase-Inhibitor-Undergoing-Clinical-Evaluation-for-the-Treatment-of-Celiac-Disease_138?oswsid=8ffa1cde7fe5a41c8fc6c325388d00f3 Zedira publication - Features of ZED1227: The First-In-Class Tissue Transglutaminase ... - 2022 -... Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and ... first in class publication features https://www.denteric.com/ Denteric: First-in-class therapeutic for treating chronic inflammation first in class therapeutic treating chronic inflammation https://www.protegobio.com/ Protego Bio - First-in-Class Therapies for Protein Misfolding Diseases Protego Bio - Accelerating the development of first-in-class therapies for protein misfolding diseases. first in class bio therapies protein diseases https://myosintherapeutics.com/ Myosin Therapeutics: First-in-Class Molecular Motor Therapies Advancing first-in-class therapies by targeting molecular motors (NMII) in oncology and neuroscience. Learn about our clinical trials for GBM, PDAC, and SUD. first in class myosin therapeutics molecular motor https://www.biopharmaapac.com/news/80/7235/innova-therapeutics-acquires-enci-therapeutics-to-advance-first-in-class-sfrp2-antibody-ivt8086-for-solid-and-haematological-cancers.html Innova Therapeutics Acquires Enci Therapeutics To Advance First in Class SFRP2 Antibody IVT8086 for... Innova Therapeutics Acquires Enci Therapeutics To Advance First in Class SFRP2 Antibody IVT8086 for Solid and Haematological Cancers first in class https://www.napnap.org/napnap_rss/us-fda-grants-accelerated-approval-to-first-in-class-glioma-drug/ US FDA Grants Accelerated Approval to First-in-Class Glioma Drug - NAPNAP first in class us fda https://www.attovia.com/ Attovia: Shaping the future of I&I with first-in-class multispecifics Dec 20, 2025 - Harnessing ATTOBODY technology to bring treatments to patients where none exist or where current solutions fall short. shaping the future https://www.rsoncology.com/companynews/aacr-2023-rso-021-a-first-in-class-treatment AACR 2023, RSO-021, a first-in-class treatment | RS Oncology first in class aacr rso https://www.lek.com/insights/biotech-and-pharmaceuticals/first-class-products-biotech First-in-Class Products for Biotech | L.E.K. Consulting Mar 24, 2026 - Within the universe of over 700 public biotech companies with a market capitalization of less than $2 billion, 160 of these companies have at least one... first in class products biotech k consulting https://www.umtm.cz/publication/impact-factor-journals/baxdrostat-first-class-aldosterone-synthase-inhibitor-resistant Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension | Institute... first in class https://www.biopharmaapac.com/news/26/2760/ark-biopharmaceutical-and-calibr-collaborate-on-potential-first-in-class-drug-for-respiratory-diseases.html Ark Biopharmaceutical and Calibr collaborate on potential first-in-class drug for respiratory... Ark Biopharmaceutical and Calibr collaborate on potential first-in-class drug for respiratory diseases first in class https://biotuesdays.com/2024/10/01/ose-immunotherapeutics-breaking-through-the-therapeutic-ceiling-with-first-in-class-immunotherapies/ OSE Immunotherapeutics breaking through the therapeutic ceiling with first-in-class immunotherapies... Jul 2, 2025 - OSE Immunotherapeutics (ISIN:FR0012127173; Mnemo:OSE) is developing and partnering therapies to control the immune system for immuno-oncology (IO) and... first in class breaking through https://www.pharmaindustrial-india.com/news/kazia-expands-oncology-platform-with-first-in-class-setdb1-inhibitor Kazia Expands Oncology Platform with First-in-Class SETDB1 Inhibitor - Global Pharma Kazia Expands Oncology Platform with First-in-Class SETDB1 Inhibitor - Global Pharma first in class https://www.vetbiolix.com/ Vetbiolix | Veterinary Biotech | First-in-Class Pet Treatments first in class veterinary biotech pet treatments https://www.altevax.com/ Altevax | A first-in-class immunotherapy against cancer Using melanin as an adjuvant, Altevax has developed an immunotherapy that triggers a strong antigen-specific immune response of CD8+ and CD4+ T cells. Altevax... first in class immunotherapy cancer https://thepharmadata.com/first-in-class-targeted-microrna-therapy-slows-cancer-tumor-growth/ First-in-class Targeted MicroRNA Therapy Slows Cancer Tumor Growth | The Pharma Data Sep 6, 2023 - First-in-class targeted microRNA therapy slows cancer tumor growth first in class https://www.sublintherapeutics.com/sublin-bv-developing-a-first-in-class-sublingual-insulin-delivery-formulation/ Sublin B.V. developing a first-in-class sublingual insulin-delivery formulation | Sublin first in class https://vivacetherapeutics.com/ Vivace | Turning novel biology into first-in-class cancer therapeutics May 7, 2026 - Vivace Therapeutics is an oncology-focused small molecule drug discovery and development company adopting a capital-efficient approach to bring novel therapies... first in class vivace turning novel biology https://www.privatehost.com/ Private Host - First-Class Web Hosting in Amsterdam. CDN for Video, Cloud Servers, DDOS Protection. Fully Managed solutions for Videos Streaming sites. Own CDN with HLS/MP4. Own High Performance Cloud. For Those who Value their Time.